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Abstract: Recently, RccHanTM:WIST (Wistar Hannover) rats were introduced to toxicity studies in Japan. The present 
study was performed to obtain control data for general toxicological parameters as an aid for interpretation of results 
in toxicity studies using this strain of rats. Four test groups comprising of 25 male and 25 female RccHanTM:WIST 
rats were housed for 2, 4, 13 or 26 weeks from 6 weeks of age and observed and examined for clinical observation, 
body weight, food consumption, urinalysis, hematology, blood chemistry, organ weight, necropsy and/or histopathology. 
Ophthalmological examination was not conducted in this study, and the data in this report were obtained from an ongo-
ing 104-week background study in RccHanTM:WIST rats. These data were compared with the historical control data of 
CD(SD) (Sprague-Dawley) and/or F344 (Fischer) rats. The body weights of RccHanTM:WIST rats were lower than those 
of CD(SD) rats and higher than those of F344 rats. The ophthalmological examination revealed a greater incidence of 
focal corneal opacity. Histopathology revealed focal mineralization of the cornea and Berlin blue-positive pigmenta-
tion in the epididymal interstitium as well as hepatocytes. Other than the above, some minor differences were found in 
urinalysis, hematology, blood chemistry and organ weights as compared with CD(SD) rats. (DOI: 10.1293/tox.24.195; J 
Toxicol Pathol 2011; 24: 195–205)
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Introduction
A few years ago, RccHanTM:WIST (Wistar Hannover) 
rats were introduced to Japan as experimental animals for 
toxicity testing of pharmaceuticals etc., being ostensibly 
able to achieve a high survival rate in long-term experiments 
and easy to handle due to their relatively small body size and 
gentle nature. Wistar Hannover rats have been widely used 
in Europe as experimental animal models in toxicity stud-
ies in rodents. In many institutes including our laboratory 
in Japan, CD(SD) (Sprague-Dawley) rats are used predomi-
nantly as experimental models in toxicity studies, and F344 
(Fischer) rats have been used as traditional animal models 
for assessing carcinogenic potential of various kinds of 
compounds. However, an epoch-making decision was made 
by NTP (National Toxicology Program), that is, the animal 
model in rat carcinogenicity studies was changed from F344 
rats to Wistar Hannover rats1. This decision exerted an im-
pact to a certain extent on researchers in the field of toxicol-
ogy, and Wistar Hannover rats began to be used in toxicity 
studies in Japan, but relatively little data are available. In 
addition, the original Wistar Hannover rats were reported 
to have a serious defect of thyroid function and morphol-
ogy2,3, and breeders made efforts to improve this defect 
via genetic cleaning. Under these circumstances, we face 
an urgent task to collect background data on Wistar Han-
nover rats. In this paper, we report historical control data of 
general toxicity parameters to clarify the biological nature 
of RccHanTM:WIST rats for up to week 26 of experiments 
(32 weeks of age), and the data were also compared with 
data for CD(SD) and/or F344 rats, though comparison with 
F344 rats was limited to body weight and food consump-
tion, since this strain of rats is used infrequently in general 
toxicity studies in our laboratory.
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Materials and Methods
Animals, animal husbandry and group composition
One hundred and ten male and 110 female 
RccHanTM:WIST SPF rats were obtained from Japan Labo-
ratory Animals, Inc. (Tokyo, Japan) at 4 weeks of age. The 
animals were quarantined and acclimatized for 2 weeks and 
used at 6 weeks of age. They were housed individually in 
stainless steel wire mesh cages in an animal room that was 
maintained at 23 ± 3 °C and 50 ± 20% relative humidity and 
with air ventilation 10 to 15 times per hour and a 12-hour 
light dark cycle. Pelleted diet (radiation sterilized CR-LPF, 
Oriental Yeast Co., Ltd., Tokyo, Japan) and drinking water 
(tap water, via automatic water supply system) were provid-
ed ad libitum. Four test groups were created, 2-, 4-, 13- and 
26-week experimental groups, and each group consisted of 
25 animals of each sex.
Clinical observations, body weight and food con-
sumption
Clinical observation was performed at least once a day, 
and body weight was measured twice a week until week 13 
and once a week thereafter. Food consumption was mea-
sured once a week.
Ophthalmology
Ophthalmological examination was not conducted in 
this study, and the data in this report were obtained from 
an ongoing 104-week background study in RccHanTM:WIST 
rats, which was started at the same time as the present study. 
In that study, examinations were performed on 100 males 
and 100 females in weeks 4, 13 and 26 of the experiment 
under the same conditions as the present study. A mydri-
atic agent (Mydrine® P, Santen Pharmaceutical Co., Ltd., 
Osaka, Japan) was applied to dilate the pupil, the anterior 
portion and optic media were then examined using a slit 
lamp (SL-15, Kowa Co., Ltd., Aichi, Japan) and the fundus 
was examined using an ophthalmoscope (Omega 200, Heine 
Optotechnik, Herrsching, Germany).
Urinalysis
In weeks 4, 13 and 26, all animals in the 26-week ex-
perimental group were examined. The following parameters 
were examined in 4-hour urine: pH, protein, ketone body, 
glucose, occult blood, bilirubin and urobilinogen (Multi-
stix® test paper, Siemens Medical Solutions Diagnostics, 
Tarrytown, NY, USA), color and sediment. The following 
parameters were examined in 20-hour urine: osmotic pres-
sure (AUTO & STAT OM-6030, Arkray, Inc., Kyoto, Japan), 
sodium, potassium and chloride (Automatic Electrolyte An-
alyzer PVA-α II, A&D Co., Ltd., Kanagawa, Japan). Water 
intake (24-hour) and urinary volume were also measured.
Hematology
At the time of necropsy at weeks 2, 4, 13 and 26, blood 
samples were collected from the abdominal aorta under di-
ethyl ether anesthesia into blood collection tubes (SB-41, 
Sysmex Corporation, Hyogo, Japan) containing EDTA-2 K. 
Prior to blood sample collection, the animals were deprived 
of food overnight. The parameters determined were red 
blood cell count (RBC), hemoglobin (HGB), hematocrit 
(HCT), mean corpuscular volume (MCV), mean corpus-
cular hemoglobin (MCH), mean corpuscular hemoglobin 
concentration (MCHC), reticulocyte ratio, platelet count, 
white blood cell count (WBC) and leukocyte differentiation 
(ADVIA® 120 Hematology System, Siemens Healthcare Di-
agnostics Inc., Deerfield, IL, USA). In addition, prothrom-
bin time (PT), activated thromboplastin time (APTT) and 
fibrinogen (ACL Elite Pro System, Instrumentation Labora-
tory, Lexington, MA, USA) were determined in the plasma 
obtained by centrifuging the blood samples treated with 3.8 
w/v% sodium citrate.
Blood chemistry
At the same time as hematology, the following param-
eters were determined in the serum: ALP, total cholesterol 
(T-CHO), triglyceride (TG), phospholipid (PL), total bili-
rubin (T-BIL), glucose (GLU), blood urea nitrogen (BUN), 
creatinine (CRNN), sodium (Na), potassium (K), chloride 
(Cl), calcium (Ca), inorganic phosphorus (P), total protein 
(TP), albumin (ALB) (Clinical Laboratory System TBA-
120FR, Toshiba Medical Systems Corporation, Tokyo, Ja-
pan), globulin, A/G ratio and protein fraction (QuickScan 
Densitometer, Helena Laboratories, Inc., Saitama, Japan). In 
addition, the following parameters were determined in the 
plasma obtained from blood treated with heparin: aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), 
lactate dehydrogenase (LDH) and creatine phosphokinase 
(CPK) (Clinical Laboratory System TBA-120FR, Toshiba 
Medical Systems Corporation, Tokyo, Japan).
Pathology
After collection of blood samples, the animals were 
exsanguinated and subjected to complete necropsy. Then, 
weights of the following organs were measured: brain, pi-
tuitary, thyroids (including parathyroids), adrenals, thymus, 
spleen, heart, lung (including bronchus), salivary glands 
(submandibular plus sublingual glands), liver, kidneys, tes-
tes/ovaries, prostate/uterus and seminal vesicles. Based on 
the above wet weight (absolute weight) and body weight 
at necropsy, organ weight per 100 g body weight (relative 
weight) was calculated. In addition to the above organs, the 
following organs were fixed with neutral buffered 10% for-
malin (however, eyeballs and optic nerves were fixed with 
fixatives containing 3% glutaraldehyde and 2.5% formalin, 
and testes and epididymides were fixed with Bouin’s solu-
tion and preserved in neutral buffered 10% formalin): spi-
nal cord, sciatic nerves, Harderian glands, submandibular 
lymph node, mesenteric lymph node, thoracic aorta, trachea, 
tongue, esophagus, stomach, duodenum, jejunum, ileum, 
cecum, colon, rectum, pancreas, urinary bladder, epididy-
mides, vagina, mammary gland, sternum (including bone 
marrow), femur (including bone marrow), femoral skeletal 
muscle, skin and any gross lesions. All of these organs/tis-Okamura, Suzuki, Ogawa et al. 197
sues were embedded in paraffin, sectioned and stained with 
hematoxylin and eosin (HE) and examined histopathologi-
cally.
The historical control data of CD(SD) [Crl:CD(SD)] rats 
fed with CR-LPF and F344 [F344/DuCrlCrlj] rats fed with 
CRF-1 were gathered from the control groups in toxicity 
studies conducted in our laboratory during the last 5 years.
The experiment was conducted in compliance with 
the laws or guidelines relating to animal welfare includ-
ing Standards Relating to the Care and Management, etc. 
of Experimental Animals (Notification No. 6 of the Prime 
Minister’s Office, Japan, March 27, 1980) and Guidelines 
for Animal Experimentation (the Japanese Association for 
Laboratory Animal Science, May 22, 1987).
Results
Mortality and clinical signs
During the 26-week experimental period, no deaths 
occurred in either sex, and no abnormalities of the clinical 
signs were observed. Additionally, RccHanTM:WIST rats 
were relatively restless and ropable upon handling in com-
parison with CD(SD) rats.
Body weights
The growth curve of the RccHanTM:WIST rats was 
lower than that of the CD(SD) rats and higher than that of 
the F344 rats for both sexes during the experimental peri-
od (Figs. 1 and 2). The mean value for body weight of the 
RccHanTM:WIST rats at 32 weeks of age was 451 g in males 
and 271 g in females, and these values were approximately 
70% to 80% of those of the CD(SD) rats (mean value: 660 g 
in males and 342 g in females) and approximately 130% to 
150% of those of the F344 rats (mean value: 342 g in males 
and 182 g in females).
Food consumption
The food consumption (g/animal/day) of the male 
RccHanTM:WIST rats was lower than that of the CD(SD) 
rats and higher than that of the F344 rats during the experi-
mental period (data not shown), while the food consumption 
of the female RccHanTM:WIST rats was comparable to or 
slightly lower than that of the CD(SD) rats and higher than 
that of the F344 rats. On the other hand, when food con-
sumption was expressed as grams per 100 g body weight per 
day, the food consumption of the RccHanTM:WIST rats was 
comparable to that of the F344 rats and higher than that of 
the CD(SD) rats in both males and females.
Ophthalmology
In the cornea of the RccHanTM:WIST rats, focal opacity 
was found by examination using a slit lamp in 88/100 males 
and 73/100 females at week 4 of the experiment (9 weeks of 
age), 89/100 males and 74/100 at week 13 of the experiment 
(18 weeks of age) and 90/100 males and 75/100 females at 
week 26 of the experiment (31 weeks of age; Table 1), and 
its incidence was much higher than in the CD(SD) rats, in 
which the incidence of this lesion is not more than about 
32% (data not shown). As might be expected, when the ex-
amination was conducted using an ophthalmoscope instead 
of a slit lamp, the incidence of corneal opacity decreased to 
less than several percent in both sexes (data not shown).
As for the lens, focal opacity was observed in only a 
few females up to week 26 of the experiment by examination 
using a slit lamp, and this is similar to the observations in 
CD(SD) rats. In weeks 4 and 13 of the experiment (up to 18 
weeks of age), particulate opacity in the lens was observed 
predominantly in the anterior cortex in both sexes; however, 
in week 26 of the experiment (31 weeks of age), opacity was 
observed predominantly in the anterior perinuclear region 
in both sexes, and this phenomenon with aging was similar 
to that of CD(SD) rats.
Fig. 1.  Body weight changes in male RccHanTM:WIST rats. For com-
parison, background data of body weight in our laboratory of 
CD(SD) rats and F344 rats are shown.
Fig. 2. Body weight changes in female RccHanTM:WIST rats. For 
comparison, background data of body weight in our labora-
tory of CD(SD) rats and F344 rats are shown.General Toxicity Parameters in RccHanTM:WIST Rats 198
In the fundus oculi, focal retinal folds were observed 
in a small number of animals at each age, and the incidence 
tended to be reduced with age. Focal hyperreflectivity of the 
fundus oculi was observed in a small number of animals at 
each age. As for frequency of their occurrence, no differ-
ence was observed between the RccHanTM:WIST rats and 
CD(SD) rats.
Urinalysis
The results are shown in Tables 2-1 to 2-3.
Urine  volume  and  one  day’s  output  of  electrolytes 
of the male RccHanTM:WIST rats were lower than in the 
CD(SD) rats (mean urine volume in CD(SD) male rats at 
week 26 of the experiment: 15.0 mL/24 h, n=168), but wa-
ter intake was comparable. In the qualitative parameters, 
a tendency for lower pH was seen in RccHanTM:WIST rats 
compared with CD(SD) rats. The number of rats with posi-
tive protein increased with age in both male and female 
RccHanTM:WIST rats and was similar to that in CD(SD) rats. 
In the qualitative parameters, there were no findings specific 
to RccHanTM:WIST rats in comparison with CD(SD) rats.
Hematology
The results are shown in Table 3.
Table 1.  Incidences of Ophthalmological Data in Nontreated RccHanTM:WIST Rats
Sex Male Female
Weeks of age 9 18 31 9 18 31
Number of animals 100 100 100 100 100 100
No abnormality 8 5 4 13 11 9
Cornea            
  Corneal opacity, focal 88 89 90 73 74 75
Iris            
  Anterior synechia 1 1 1 0 0 0
Anterior chamber            
  Residue in anterior chamber, adhesion endothelium of cornea 1 1 1 1 1 0
  Aqueous flare 1 0 0 0 0 0
Lens            
  Anterior cortex            
  Particulate  opacity 34 36 15 25 28 5
  Focal  opacity 2 2 0 0 2 4
  Anterior perinuclear            
  Particulate  opacity 0 0 32 0 0 33
  Focal  opacity 0 0 4 0 0 1
 Nucleus            
  Particulate  opacity 1 5 6 0 1 4
  Posterior cortex            
  Particulate  opacity 24 19 14 14 13 13
 Equator            
  Particulate  opacity 0 0 1 0 0 0
Vitreous body            
  Vitreous opacity, focal 0 1 0 0 0 0
Fundus oculi            
  Retinal fold, focal 4 2 0 8 3 1
  Hyperreflectivity in fundus, focal 1 2 2 1 1 1
Table 2-1.  Urinalysis Data for Nontreated RccHanTM:WIST Rats
Sex
Weeks 
of  
age
Number 
of  
animals
pH Protein 
(mg/dL)
Ketones 
(mg/dL)
Glucose 
(mg/dL)
Occult blood 
(mg/dL)
Urobilinogen 
(E.U./dL)
Bilirubin 
(mg/dL)
6.0 6.5 7.0 7.5 8.0 8.5 ≥9.0 – ± 1+ 2+ 3+ – ± 1+ – 1+ – ± 1+ 2+ 3+ ± 1+ 2+ ± 1+
Male
9 25 0 0 0 0 1 19 5 0 9 15 1 0 19 6 0 25 0 22 3 0 0 0 25 0 0 25 0
18 25 0 1 3 3 6 10 2 0 9 16 0 0 20 5 0 25 0 15 9 1 0 0 25 0 0 25 0
31 25 3 0 3 4 2 10 3 0 1 12 12 0 17 4 4 24 1 17 8 0 0 0 24 1 0 23 2
Female
9 25 0 0 2 4 6 10 3 20 5 0 0 0 24 1 0 25 0 23 1 0 0 1 25 0 0 25 0
18 25 2 3 3 4 3 10 0 22 3 0 0 0 25 0 0 24 1 23 2 0 0 0 25 0 0 25 0
31 25 7 5 4 4 1 4 0 8 11 2 3 1 20 3 2 22 3 24 0 1 0 0 22 2 1 22 3
Protein: −, +/−, 1+, 2+ and 3+ represent negative and 15, 30, 100 and 300 mg/dL, respectively.  Ketones: −, +/− and 1+ represent negative and 5 and 15 mg/
dL, respectively.  Glucose: − and 1+ represent negative and 100 mg/dL, respectively.  Occult blood: −, +/−, 1+, 2+ and 3+ represent negative and 0.015, 
0.062, 0.135 and 0.405 mg/dL, respectively.  Urobilinogen: +/−, 1+ and 2+ represent 0.1-1.0, 2.0, and 4.0 E.U./dL, respectively.  Bilirubin: − and 1+ rep-
resent negative and 0.8 mg/dL, respectively.Okamura, Suzuki, Ogawa et al. 199
In both sexes of RccHanTM:WIST rats, tendencies for a 
decrease in white blood cell count, lymphocyte count, plate-
let count and fibrinogen were observed with age, and they 
were similar to those of the CD(SD) rats.
A majority of the parameters of the RccHanTM:WIST 
rats were comparable to those of the CD(SD) rats, but the 
white blood cell count was remarkably lower than in both 
sexes of CD(SD) rats (mean WBC counts in CD(SD) rats at 
10, 19 and 32 weeks of age: 92.6, 102.1 and 92.7 × 102/μL 
for males and 79.4, 65.4 and 54.4 × 102/μL for females, re-
spectively, n=130–160/age/sex); however, the count of each 
leukocyte fraction was comparable between the two strains.
Blood chemistry
The results are shown in Table 4.
In both sexes of RccHanTM:WIST rats, ALP activity 
and inorganic phosphorus decreased with age, and this phe-
nomenon is well-known in rats. In addition, a tendency for 
a decrease in CPK activity and tendencies for an increase in 
glucose and gamma globulin were observed in both sexes 
with age.
Plasma ALP activity at each age of RccHanTM:WIST 
rats was lower than in CD(SD) rats in both sexes (mean ac-
tivity in CD(SD) rats at 10, 19 and 32 weeks of age: 715, 
309 and 268 IU/L for males and 419, 151 and 101 IU/L for 
females, respectively, n=150–260/age/sex). In addition, ALT 
and LDH activities, total cholesterol, triglyceride and phos-
pholipid levels in the female RccHanTM:WIST rats were low-
er than in the CD(SD) rats at 32 weeks of age, and the BUN 
levels in both sexes were higher than in the CD(SD) rats at 
each age (Fig. 3).
Organ weights
The results are shown in Tables 5 and 6.
The relative weights of the adrenals (both sexes), testes 
and ovaries in the RccHanTM:WIST rats tended to be higher 
than in the CD(SD) rats at 10, 19 and 32 weeks of age, and 
the relative weight of the thymus also tended to be higher 
than in the CD(SD) rats in both sexes at 19 and 32 weeks of 
age (Fig. 4).
Necropsy
The results are shown in Table 7.
There  were  no  gross  findings  specific  to  the 
RccHanTM:WIST rats.
Histopathology
The characteristic findings in the RccHanTM:WIST rats 
compared with CD(SD) rats are shown in Table 8.
Histopathological  findings  characteristic  to 
RccHanTM:WIST rats were observed in the eye, liver and 
epididymis. In the eye, a greater incidence of corneal min-
eralization was observed at each age (Fig. 5) and was more 
predominant in males than females; however, the incidence 
and severity were comparable among ages. In the liver, Ber-
lin blue-positive pigmentation of periportal hepatocytes 
was observed in a few animals at each age. In most cases, 
Kupffer cells also contained the pigments. Pigment-laden 
macrophages were also noted in the epididymal intersti-
tium, and the incidence was increased with age; almost all 
males were affected at week 26 of the experiment (22 out of 
25 males). The pigments in the epididymis were also posi-
tive for Berlin blue and weakly positive for the Schmorl re-
Table 2-2.  Urinalysis Data for Nontreated RccHanTM:WIST Rats
Sex
Weeks 
of age
Number 
of animals
Color Red blood cells White blood cells Ep.SEC Ep.SREC Cast Cr.PS Cr.CO
Yellow −  ± −  ±  ± − − −  ± −
Male
9 25 25 24 1 25 0 25 25 25 19 6 25
18 25 25 25 0 25 0 25 25 25 25 0 25
31 25 25 22 3 24 1 25 25 25 21 4 25
Female
9 25 25 24 1 25 0 25 25 25 17 8 25
18 25 25 25 0 25 0 25 25 25 21 4 25
31 25 25 24 1 24 1 25 25 25 24 1 25
Cr.PS: Crystal phosphate salts.  Cr.CO: Crystal calcium oxalate.  Ep.SEC: Squamous epithelial cells.  Ep.SREC: Small round epithelial 
cells.  −: Negative.  +/−: Slight.
Table 2-3.  Urinalysis Data for Nontreated RccHanTM:WIST Rats
Sex
Weeks 
of age
Number 
of animals
Urine volume Water intake Osmolality Na K Cl
(mL/24 h) (mL/24 h) (mOsm/kg) (mmol/24 h) (mmol/24 h) (mmol/24 h)
Male
9 25 8.6 ± 4.3 a) 37 ± 6 1867 ± 445 1.3 ± 0.5 2.9 ± 1.0 1.8 ± 0.6
18 25 9.4 ± 5.2 38 ± 8 1917 ± 536 1.4 ± 0.4 2.7 ± 0.7 1.9 ± 0.5
31 25 11.0 ± 5.4 38 ± 9 1531 ± 444 1.1 ± 0.3 2.6 ± 0.6 1.5 ± 0.4
Female
9 25 6.8 ± 3.0 32 ± 6 1682 ± 423 0.9 ± 0.3 1.9 ± 0.7 1.2 ± 0.4
18 25 8.1 ± 4.1 37 ± 7 1583 ± 537 0.9 ± 0.3 1.8 ± 0.6 1.3 ± 0.4
31 25 10.5 ± 7.5 38 ± 16 1325 ± 434 0.9 ± 0.3 1.9 ± 0.7 1.2 ± 0.4
a) Values are means ± SD.General Toxicity Parameters in RccHanTM:WIST Rats 200
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Table 6.  Relative Organ Weight Data for Nontreated RccHanTM:WIST Rats
Sex Male Female
Weeks of age 10 19 32 10 19 32
Number of animals 25 25 25 25 25 25
Body weight on the day of necropsy (g) 262 ± 16 a) 381 ± 20 429 ± 32 168 ± 10 222 ± 18 254 ± 20
Brain (g/100 g) 0.72 ± 0.03 0.53 ± 0.03 0.48 ± 0.03 1.05 ± 0.06 0.84 ± 0.06 0.76 ± 0.05
Pituitary (mg/100 g) 3.1 ± 0.4 2.5 ± 0.2 2.2 ± 0.3 5.9 ± 0.7 6.5 ± 0.8 6.1 ± 0.9
Thyroid gland (mg/100 g) 5.5 ± 1.1 5.5 ± 0.7 5.2 ± 0.8 7.9 ± 1.2 7.4 ± 1.0  7.2 ± 1.3
Salivary gland (mg/100 g) 181 ± 17  162 ± 15  147 ± 13  202 ± 17  183 ± 18  183 ± 18 
Thymus (mg/100 g) 165 ± 25 82 ± 18 49 ± 9 235 ± 36 129 ± 44 81 ± 12
Heart (g/100 g) 0.30 ± 0.02 0.25 ± 0.02 0.23 ± 0.01 0.33 ± 0.02 0.30 ± 0.04  0.28 ± 0.02
Lung (g/100 g) 0.40 ± 0.02 0.32 ± 0.02 0.29 ± 0.02 0.47 ± 0.03 0.42 ± 0.02 0.38 ± 0.02
Liver (g/100 g) 2.90 ± 0.13 2.34 ± 0.13 2.22 ± 0.14 2.86 ± 0.15 2.47 ± 0.19 2.25 ± 0.12
Spleen (g/100 g) 0.20 ± 0.02 0.16 ± 0.02 0.15 ± 0.02 0.22 ± 0.04 0.20 ± 0.02 0.20 ± 0.03
Kidney (g/100 g) 0.70 ± 0.0  0.55 ± 0.03  0.50 ± 0.03  0.73 ± 0.04  0.62 ± 0.04  0.58 ± 0.04 
Adrenal (mg/100 g) 24 ± 3  17 ± 2 12 ± 2 38 ± 5 30 ± 4 25 ± 4
Testis (g/100 g) 1.18 ± 0.10  0.94 ± 0.10  0.86 ± 0.07 NA NA NA
Prostate (g/100 g) 0.20 ± 0.03 0.24 ± 0.03 0.25 ± 0.03 NA NA NA
Seminal vesicles (g/100 g) 0.20 ± 0.03 0.28 ± 0.05 0.27 ± 0.04 NA NA NA
Ovary (mg/100 g) NA NA NA 43.5 ± 8.4 41.5 ± 7.1 33.8 ± 6.9
Uterus (mg/100 g) NA NA NA 219 ± 45 251 ± 52 263 ± 54
a) Values are means ± SD. NA: Not applicable
Fig. 3.  Comparison of blood chemical data of male (A) and female 
(B) RccHanTM:WIST rats and CD(SD) rats. Each parameter of 
RccHanTM:WIST rats is shown as the relative value over each 
value of CD(SD) rats at 32 weeks of age.
Table 5.  Absolute Organ Weight Data for Nontreated RccHanTM:WIST Rats
Sex Male Female
Weeks of age 10 19 32 10 19 32
Number of animals 25 25 25 25 25 25
Body weight on the day of necropsy (g) 262 ± 16 a) 381 ± 20 429 ± 32 168 ± 10 222 ± 18 254 ± 20
Brain (g) 1.89 ± 0.06 2.03 ± 0.06 2.07 ± 0.07 1.75 ± 0.06 1.85 ± 0.05 1.92 ± 0.06
Pituitary (mg) 8.2 ± 1.0  9.7 ± 1.0  9.5 ± 1.2 9.8 ± 1.1 14.4 ± 2.0  15.3 ± 1.9
Thyroid gland (mg) 14.4 ± 2.9 20.9 ± 2.5 22.3 ± 3.9 13.3 ± 2.4 16.4 ± 2.5 18.2 ± 3.4
Salivary gland (mg) 475 ± 50  616 ± 62  630 ± 57  339 ± 32  405 ± 43  462 ± 36 
Thymus (mg) 433 ± 73 313 ± 68 212 ± 38 394 ± 62 285 ± 89 205 ± 29
Heart (g) 0.80 ± 0.05 0.97 ± 0.09 0.99 ± 0.07 0.6 ± 0.03 0.66 ± 0.10  0.72 ± 0.06
Lung (g) 1.05 ± 0.09 1.21 ± 0.07 1.25 ± 0.08 0.79 ± 0.06 0.92 ± 0.06 0.96 ± 0.06
Liver (g) 7.61 ± 0.63 8.91 ± 0.81 9.53 ± 1.04 4.80 ± 0.40  5.50 ± 0.68 5.70 ± 0.41
Spleen (g) 0.53 ± 0.07 0.60 ± 0.07 0.63 ± 0.09 0.37 ± 0.07 0.44 ± 0.07 0.51 ± 0.06
Kidney (g) 1.82 ± 0.15  2.10 ± 0.15  2.13 ± 0.16  1.22 ± 0.08  1.38 ± 0.15  1.46 ± 0.12 
Adrenal (mg) 63 ± 9 64 ± 8 51 ± 7 64 ± 8 65 ± 8 64 ± 8
Testis (g) 3.07 ± 0.22 3.56 ± 0.32 3.69 ± 0.32 NA NA NA
Prostate (g) 0.52 ± 0.08 0.91 ± 0.11 1.07 ± 0.14 NA NA NA
Seminal vesicles (g) 0.52 ± 0.10  1.06 ± 0.18 1.14 ± 0.17 NA NA NA
Ovary (mg) NA NA NA 72.9 ± 14.2 91.7 ± 14.5 85.3 ± 16.2
Uterus (mg) NA NA NA 367 ± 78 556 ± 119 667 ± 134
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action (Fig. 6).
Although the original Wistar Hannover rats were re-
ported to have serious defects of thyroid function and mor-
phology2,3, there were no dysplastic lesions in the thyroid 
gland in any animal in the present study at least up to week 
26 of the experiment.
Discussion
The body weights of the male and female 
RccHanTM:WIST rats were lower than those of the CD(SD) 
rats and higher than those of the F344 rats and fell be-
tween the two strains. The ophthalmological examination 
revealed a greater incidence of focal corneal opacity in 
RccHanTM:WIST rats when viewed with a slit lamp. Histo-
pathology revealed focal mineralization of the cornea, and 
thus, it was considered that mineralization was involved in 
Fig. 4.  Comparison of relative organ weights of male (A, B and C) and female (D, E and F) RccHanTM:WIST rats and CD(SD) rats at 8 (A 
and D), 19 (B and E) and 32 (C and F) weeks of age. Each parameter of RccHanTM:WIST rats is shown as the relative value over each 
value of CD(SD) rats.
Table 7.  Gross Pathological Findings in Nontreated RccHanTM:WIST Rats
Sex Male Female
Weeks of age 8 10 19 32 8 10 19 32
Number of animals 25 25 25 25 25 25 25 25
Liver
  Hepatodiaphragmatic nodule 0  0  1  0  0  0  0  0 
Lung (bronchus)
  Focus, dark red 0  2  0  0  0  0  0  0 
Stomach
  Focus, white 0  0  1  0  0  0  0  0 
  Focus, dark red, glandular stomach 0  0  0  0  0  1  4  2 
Thyroid
 Small 0  1  0  0  0  0  0  0 
Vagina
 Cyst NA NA NA NA 0  1  0  0 
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corneal opacity. Since the serum calcium levels were com-
parable among strains, it was not due to a high serum cal-
cium level. In comparison with CD(SD) rats, clinical pathol-
ogy in the RccHanTM:WIST rats revealed lower values for 
urine volume, one day’s output of electrolytes into the urine, 
peripheral white blood cell count without differential leuko-
cyte ratio and plasma levels of ALP, ALT and LDH activities 
in males and/or females. The reasons for these differences 
were obscure, but they might be related to the small body 
size of the RccHanTM:WIST rats. BUN levels were higher 
in RccHanTM:WIST rats than in CD(SD) rats, but there was 
no evidence of renal tubular damage in histopathology of 
the kidney. Therefore, these were considered to be minor 
differences. In addition to the aforementioned corneal min-
eralization, histopathology revealed Berlin blue-positive 
pigments in the periportal hepatocytes, and this finding in 
the Wistar Hannover GALAS rat has also been described in 
other papers4. Pigment-laden macrophages were also found 
Fig. 5.  Corneal mineralization in the eyes of RccHanTM:WIST rats at 19 weeks of age (A to C, arrowheads). H.E. staining, ×400.
Fig. 6.  Histopathological findings in the epididymis of RccHanTM:WIST rats at 32 weeks of age. (A) Pigment-laden macrophages were ob-
served in the epididymal interstitium. H.E. staining, ×400. (B and C) The pigments in the epididymis were also positive for Berlin blue 
(B) and weakly positive for the Schmorl reaction (C). ×400.
Table 8.  Histopathological Characteristics of Nontreated RccHanTM:WIST Rats
Sex Male Female
Weeks of age 10 19 32 10 19 32
Number of animals 25 25 25 25 25 25
Liver
  Pigmentation, hepatocytic (Total) 0  4  2  1 2 1
  Minimal 0  4  1  0 0 1
  Mild 0  0  1  1 2 0
Epididymis
  Pigmented macrophage, interstitial (Total) 3  18  22  NA NA NA
  Minimal 3  18  22  NA NA NA
Eye
  Atrophy, retinal (Total) 0  0  3  1 1 8
  Minimal 0  0  3  1 1 5
  Mild 0  0  0  0 0 3
  Mineralization, corneal (Total) 9  15  10  5 4 6
  Minimal 9  15  10  5 4 6
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in the epididymal interstitium. The pigments were Berlin 
blue-positive and weakly positive for the Schmorl reaction, 
but identification could not be done. Measurement of organ 
weights revealed higher values for the relative weights of the 
adrenals, testes and ovaries in RccHanTM:WIST rats in com-
parison with CD(SD) rats, and again, this might be related to 
the small body size of the RccHanTM:WIST rats. It is likely 
that a certain large size is necessary to exert the function for 
the endocrine and reproductive organs.
We are now conducting a 104-week experiment in 
RccHanTM:WIST rats, and control data will be reported in 
the near future.
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